iRhythm Holdings (IRTC) Cash & Equivalents Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | -36.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.01% |
| Dec 31, 2025 | -66.06% |
| Sep 30, 2025 | -68.73% |
| Jun 30, 2025 | -43.86% |
| Mar 31, 2025 | -27.89% |
| Dec 31, 2024 | 1,059.97% |
| Sep 30, 2024 | 994.26% |
| Jun 30, 2024 | 794.07% |
| Mar 31, 2024 | 885.57% |
| Dec 31, 2023 | -54.11% |
| Sep 30, 2023 | 92.09% |
| Jun 30, 2023 | 15.16% |
| Mar 31, 2023 | -44.29% |
| Dec 31, 2022 | -38.20% |
| Sep 30, 2022 | -81.33% |
| Jun 30, 2022 | -61.50% |
| Mar 31, 2022 | -31.00% |
| Dec 31, 2021 | 113.23% |
| Sep 30, 2021 | 77.04% |
| Jun 30, 2021 | 69.92% |
| Mar 31, 2021 | 143.08% |
| Dec 31, 2020 | 192.36% |
| Sep 30, 2020 | 115.93% |
| Jun 30, 2020 | 411.32% |
| Mar 31, 2020 | 101.11% |
| Dec 31, 2019 | 35.59% |
| Sep 30, 2019 | -55.14% |
| Jun 30, 2019 | -16.93% |
| Mar 31, 2019 | -68.88% |
| Dec 31, 2018 | -85.24% |
| Sep 30, 2018 | -26.77% |
| Jun 30, 2018 | 21,043.96% |
| Mar 31, 2018 | 479.51% |
| Dec 31, 2017 | -8.14% |
| Sep 30, 2017 | 1,730.15% |
| Jun 30, 2017 | -98.99% |
| Mar 31, 2017 | 9.39% |
| Dec 31, 2016 | 341.63% |
| Sep 30, 2016 | -19.17% |